483 Document: Bi-Coastal Pharma International, Jan 14, 2022

FDANews 483 Bi-Coastal Pharma International Jan 14 2022 top
Rose L. Jean-Mary FDA Investigator Guerlain Ulysse FDA Investigator

On Jan 14, 2022, the FDA inspected Bi-Coastal Pharma International's Shrewsbury site. Explore the inspectional observations.